APA ציטוט

Morel, N., Chabarttier, C., Merson, L., Lelias, A., Bernard, J., Delaunay, F., . . . Janvier, G. (2012). Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience. Medknow Publications & Media Pvt Ltd.

Citação norma Chicago

Morel, Nicolas, Cyrille Chabarttier, Laurent Merson, Agathe Lelias, Jean-Christophe Bernard, François Delaunay, Philippe Dabadie, and Gérard Janvier. Advantage of Using a Recombinant Activated Factor VII in Traumatic Haemorrhagic Shock: The Bordeaux Experience. Medknow Publications & Media Pvt Ltd, 2012.

ציטוט MLA

Morel, Nicolas, et al. Advantage of Using a Recombinant Activated Factor VII in Traumatic Haemorrhagic Shock: The Bordeaux Experience. Medknow Publications & Media Pvt Ltd, 2012.